Literature DB >> 22545584

Judging cheaters: is substance misuse viewed similarly in the athletic and academic domains?

Tonya Dodge1, Kevin J Williams, Miesha Marzell, Rob Turrisi.   

Abstract

The present study examines how individuals judge others who use performance-enhancing drugs in two different domains--the athletic domain and the academic domain. Approximately 1,200 males in their freshman year of college completed a questionnaire that included two scenarios. One scenario described an athlete who misused anabolic steroids to help him succeed at a sporting event. The other described a college student who misused Adderall to help him succeed on his midterm exams. Participants rated the extent to which they thought the target had cheated and the extent to which they felt the substances were necessary for success. Results showed participants believed the athlete was more of a cheater than the student, and this difference got larger as past prescription stimulant misuse increased. Results also demonstrated that participants felt Adderall was more necessary than anabolic steroids for bringing about success. Contributions to the literature on zero-sum and non-zero-sum domains are discussed. Implications for future research and efforts to prevent substance misuse are described. PsycINFO Database Record (c) 2012 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22545584      PMCID: PMC3445768          DOI: 10.1037/a0027872

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  25 in total

1.  Anabolic-androgenic steroid use disorders among a sample of Australian competitive and recreational users.

Authors:  J Copeland; R Peters; P Dillon
Journal:  Drug Alcohol Depend       Date:  2000-07-01       Impact factor: 4.492

2.  Cognitive enhancement, cheating, and accomplishment.

Authors:  Rob Goodman
Journal:  Kennedy Inst Ethics J       Date:  2010-06

3.  Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey.

Authors:  Sean Esteban McCabe; John R Knight; Christian J Teter; Henry Wechsler
Journal:  Addiction       Date:  2005-01       Impact factor: 6.526

4.  Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys.

Authors:  Sean Esteban McCabe; Kirk J Brower; Brady T West; Toben F Nelson; Henry Wechsler
Journal:  Drug Alcohol Depend       Date:  2007-05-23       Impact factor: 4.492

5.  Misperceptions of non-medical prescription drug use: a web survey of college students.

Authors:  Sean Esteban McCabe
Journal:  Addict Behav       Date:  2007-12-27       Impact factor: 3.913

6.  Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program.

Authors:  L Goldberg; D Elliot; G N Clarke; D P MacKinnon; E Moe; L Zoref; C Green; S L Wolf; E Greffrath; D J Miller; A Lapin
Journal:  JAMA       Date:  1996-11-20       Impact factor: 56.272

Review 7.  Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases.

Authors:  S Basaria; J T Wahlstrom; A S Dobs
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

Review 8.  Anabolic steroids for the treatment of weight loss in HIV-infected individuals.

Authors:  K Johns; M J Beddall; R C Corrin
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

9.  Modeling population heterogeneity in appearance- and performance-enhancing drug (APED) use: applications of mixture modeling in 400 regular APED users.

Authors:  Thomas Hildebrandt; James W Langenbucher; Sasha J Carr; Pilar Sanjuan
Journal:  J Abnorm Psychol       Date:  2007-11

10.  A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial.

Authors:  Eva C Creutzberg; Emiel F M Wouters; Rob Mostert; Rob J Pluymers; Annemie M W J Schols
Journal:  Chest       Date:  2003-11       Impact factor: 9.410

View more
  9 in total

1.  From recreational to functional drug use: the evolution of drugs in American higher education, 1960-2014.

Authors:  Ross D Aikins
Journal:  Hist Educ       Date:  2014-12-17

2.  "The White Version of Cheating?" Ethical and Social Equity Concerns of Cognitive Enhancing Drug Users in Higher Education.

Authors:  Ross Aikins
Journal:  J Acad Ethics       Date:  2018-12-11

Review 3.  Prescription stimulant medication misuse: Where are we and where do we go from here?

Authors:  Lisa L Weyandt; Danielle R Oster; Marisa E Marraccini; Bergljot Gyda Gudmundsdottir; Bailey A Munro; Emma S Rathkey; Alison McCallum
Journal:  Exp Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.157

Review 4.  Attitudes toward pharmacological cognitive enhancement-a review.

Authors:  Kimberly J Schelle; Nadira Faulmüller; Lucius Caviola; Miles Hewstone
Journal:  Front Syst Neurosci       Date:  2014-04-17

5.  Nonmedical Use of Prescription Stimulants Among US High School Students to Help Study: Results From a National Survey.

Authors:  Christian J Teter; Christopher G DiRaimo; Brady T West; Ty S Schepis; Sean Esteban McCabe
Journal:  J Pharm Pract       Date:  2018-07-02

6.  Subjective stressors in school and their relation to neuroenhancement: a behavioral perspective on students' everyday life "doping".

Authors:  Wanja Wolff; Ralf Brand
Journal:  Subst Abuse Treat Prev Policy       Date:  2013-06-18

7.  Cerebral Correlates of Automatic Associations Towards Performance Enhancing Substances.

Authors:  Sebastian Schindler; Wanja Wolff
Journal:  Front Psychol       Date:  2015-12-22

8.  The Complexity of Neuroenhancement and the Adoption of a Social Cognitive Perspective.

Authors:  Arnaldo Zelli; Fabio Lucidi; Luca Mallia
Journal:  Front Psychol       Date:  2015-12-01

9.  Swiss University Students' Attitudes toward Pharmacological Cognitive Enhancement.

Authors:  Larissa J Maier; Evangelia Liakoni; Jan Schildmann; Michael P Schaub; Matthias E Liechti
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.